MPG.eBooks - Search Results

Cover Image

21

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2019

CADTH

Cover Image

22

CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

23

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

24

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

25

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

26

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

27

CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

28

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

29

CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals Canada Inc.) : indication : secondary progressive multiple sclerosis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

30

CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

31

CADTH Canadian Drug Expert Committee recommendation: Tofacinitib (Xeljanz) : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

32

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

33

CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

34

CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

35

CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

36

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

Cover Image

37

CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients 1 yea...

Published 2019

CADTH

Cover Image

38

CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB Canada Inc.) : indication : treatment of adult patients with moderate-to severe plaqu...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

39

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

40

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6
7
8
9
10
11